These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 606739)

  • 1. Accumulation of technetium-99m stannous pyrophosphate in contused myocardium.
    Downey J; Chagrasulis R; Fore D; Parmley LF
    J Nucl Med; 1977 Dec; 18(12):1171-5. PubMed ID: 606739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocsrdial uptake of technetium-99m stannous pyrophosphate following direct current transthoracic countershock.
    DiCola VC; Freedman GS; Downing SE; Zaret BL
    Circulation; 1976 Dec; 54(6):980-6. PubMed ID: 991415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
    Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT
    J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial uptake of technetium-99m stannous pyrophosphate in experimental viral myopericarditis.
    Kadota K; Matsumori A; Kambara H; Kawai C
    J Nucl Med; 1979 Oct; 20(10):1047-50. PubMed ID: 231641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of myocardial injury produced by temporary coronary artery occlusion and reflow with technetium-99m-pyrophosphate.
    Jansen DE; Corbett JR; Buja LM; Hansen C; Ugolini V; Parkey RW; Willerson JT
    Circulation; 1987 Mar; 75(3):611-7. PubMed ID: 3493088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
    Huckell VF; Lyster DM; Morrison RT; Cooper JA
    Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m stannous pyrophosphate myocardial scintigraphy in the recognition of acute subendocardial myocardial infarction.
    Poliner LR; Parkey RW; Buja LM; Stokely EM; Bonte FJ; Willerson JT
    Tex Med; 1977 Aug; 73(8):74-81. PubMed ID: 882934
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro technetium-99m red blood cell labeling using commercial stannous pyrophosphate.
    Zimmer AM
    Am J Hosp Pharm; 1977 Mar; 34(3):264-7. PubMed ID: 857670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m(Sn2+)pyrophosphate in ischemic and infarcted dog myocardium in early stages of acute coronary occlusion: histochemical and tissue-counting comparisons.
    Bianco JA; Kemper AJ; Taylor A; Lazewatsky J; Tow DE; Khuri SF
    J Nucl Med; 1983 Jun; 24(6):485-91. PubMed ID: 6854398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous display of gated technetium-99m stannous pyrophosphate and gated blood-pool scintigrams.
    Corbett JR; Lewis SE; Dehmer G; Bonte FJ; Parkey RW; Buja LM; Willerson JT
    J Nucl Med; 1981 Aug; 22(8):671-7. PubMed ID: 7264755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m labeling of polymorphonuclear leukocytes: preparation with two different stannous agents.
    Kelbaek H; Fogh J
    J Nucl Med; 1985 Jan; 26(1):68-71. PubMed ID: 3965654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Technetium-99m stannous pyrophosphate myocardial scintigraphy].
    Tada A; Bungyo H; Hisada K
    Rinsho Hoshasen; 1983 Feb; 28(2):345-6. PubMed ID: 6865056
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Stability of stannous ion in stannous pyrophosphate kits.
    Kowalsky RJ; Chilton HM
    J Nucl Med; 1983 Nov; 24(11):1080-1. PubMed ID: 6631529
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms contributing to myocardial accumulation of technetium-99m stannous pyrophosphate after coronary arterial occlusion.
    Coleman RE; Klein MS; Ahmed SA; Weiss ES; Buchholz WM; Sobel BE
    Am J Cardiol; 1977 Jan; 39(1):55-9. PubMed ID: 188332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative myocardial infarction diagnosed by technetium 99m stannous pyrophosphate myocardial scintigrams.
    Platt MR; Mills LJ; Parkey RW; Willerson JT; Bonte FJ; Shapiro W; Sugg WL
    Circulation; 1976 Dec; 54(6 Suppl):III24-7. PubMed ID: 991422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial uptake of Tc-99m skeletal agents in the rat after experimental induction of microscopic foci of injury.
    Miller DG; Gilmour RF; Grossman ZD; Mallov S; Wistow BW; Rohner RF
    J Nucl Med; 1977 Oct; 18(10):1005-9. PubMed ID: 198448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the labeling of streptokinase with 99mTc for use as a radiopharmaceutical in the detection of deep-vein thrombosis: concise communication.
    Duffy MJ; Duffy GJ
    J Nucl Med; 1977 May; 18(5):483-5. PubMed ID: 16092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myocardial infarction: clinical application of technetium 99m stannous pyrophosphate infarct scintigraphy.
    Werner JA; Botvinick EH; Shames DM; Parmley WW
    West J Med; 1977 Dec; 127(6):464-78. PubMed ID: 339549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of methylprednisolone upon technetium-99m pyrophosphate assessment myocardial necrosis in the canine countershock model.
    Schneider RM; Hayslett JP; Downing SE; Berger HJ; Donabedian RK; Zaret BL
    Circulation; 1977 Dec; 56(6):1029-34. PubMed ID: 923041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.